{
    "code": "02024084",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02024084",
    "time": "2017-04-28 03:29:12",
    "許可證字號": "衛署藥輸字第024084號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "108\/10\/14",
    "發證日期": "93\/10\/14",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202408405",
    "中文品名": "愛寧達注射劑",
    "英文品名": "ALIMTA (PEMETREXED FOR INJECTION) 500MG",
    "適應症": "1.併用cisplatin是治療局部晚期或轉移性非小細胞肺癌（顯著鱗狀細胞組織型除外）之第一線化療用藥。2.Alimta單一藥物是局部晚期或轉移性非小細胞肺癌(顯著麟狀細胞組織型除外)病人接受4個週期含鉑藥物的第一線化療後疾病並未惡化之維持療法。3.單一藥物是治療局部晚期或轉移性非小細胞肺癌（顯著鱗狀細胞組織型除外）之第二線治療用藥。4.與cisplatin併用於治療惡性肋膜間質細胞瘤。",
    "劑型": "243凍晶注射劑",
    "包裝": "500公絲小瓶 、100支以下盒裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "主成分略述": [
        "PEMETREXEDDISODIUMHEPTAHYDRATE"
    ],
    "限制項目": "02輸　入",
    "申請商名稱": "1411301100  台灣禮來股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F460073100  ELI LILLY AND COMPANY",
        "製造廠廠址": "INDIANAPOLIS, INDIANA 46285, U.S.A.",
        "製造廠公司地址": "",
        "": ""
    },
    "CCC號列": "30049071005 抗癌藥Anti-cancer preparations",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1004002410",
            "成分名稱": "PEMETREXED DISODIUM HEPTAHYDRATE",
            "含量描述": "",
            "含量": "713.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "Alimta leaflet-104-09-30(廠商自行上傳).pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024084&Seq=108&Type=9"
        },
        {
            "title": "Alimta 500-104-09-30(廠商自行上傳).pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024084&Seq=001&Type=8"
        }
    ]
}